Suzuki S - Search Results

1

Antigen-specific T-cell activation in hyperplastic thymus in myasthenia gravis.

Utsugisawa K, Nagane Y, Suzuki S, Kondoh R. Utsugisawa K, et al. Among authors: suzuki s. Muscle Nerve. 2007 Jul;36(1):100-3. doi: 10.1002/mus.20794. Muscle Nerve. 2007. PMID: 17471566

2

Initial predictors of development of pure red cell aplasia in myasthenia gravis after thymectomy.

Suzuki S, Nogawa S, Tanaka K, Koto A, Fukuuchi Y, Kuwana M. Suzuki S, et al. Clin Neurol Neurosurg. 2003 Dec;106(1):16-8. doi: 10.1016/s0303-8467(03)00061-1. Clin Neurol Neurosurg. 2003. PMID: 14643910

3

[A patient with giant cell myocarditis and myositis associated with thymoma and myasthenia gravis].

Sato H, Iwasaki E, Nogawa S, Suzuki S, Amano T, Fukuuchi Y, Shimoda M, Okada Y. Sato H, et al. Among authors: suzuki s. Rinsho Shinkeigaku. 2003 Aug;43(8):496-9. Rinsho Shinkeigaku. 2003. PMID: 14658403 Japanese.

4

[A case of Good syndrome accompanied by myasthenia gravis: immunological evaluations].

Katsuki Y, Suzuki S, Takahashi Y, Satoh T, Nogawa S, Tanaka K, Suzuki N, Kuwana M. Katsuki Y, et al. Among authors: suzuki n, suzuki s. Nihon Rinsho Meneki Gakkai Kaishi. 2006 Apr;29(2):102-6. doi: 10.2177/jsci.29.102. Nihon Rinsho Meneki Gakkai Kaishi. 2006. PMID: 16651708 Free article. Japanese.

5

Classification of myasthenia gravis based on autoantibody status.

Suzuki S, Utsugisawa K, Nagane Y, Satoh T, Terayama Y, Suzuki N, Kuwana M. Suzuki S, et al. Among authors: suzuki n. Arch Neurol. 2007 Aug;64(8):1121-4. doi: 10.1001/archneur.64.8.1121. Arch Neurol. 2007. PMID: 17698702

6

Autoimmune targets of heart and skeletal muscles in myasthenia gravis.

Suzuki S, Utsugisawa K, Yoshikawa H, Motomura M, Matsubara S, Yokoyama K, Nagane Y, Maruta T, Satoh T, Sato H, Kuwana M, Suzuki N. Suzuki S, et al. Among authors: suzuki n. Arch Neurol. 2009 Nov;66(11):1334-8. doi: 10.1001/archneurol.2009.229. Epub 2009 Sep 14. Arch Neurol. 2009. PMID: 19752287

7

Factors associated with response to calcineurin inhibitors in myasthenia gravis.

Nagane Y, Suzuki S, Suzuki N, Utsugisawa K. Nagane Y, et al. Among authors: suzuki n, suzuki s. Muscle Nerve. 2010 Feb;41(2):212-8. doi: 10.1002/mus.21462. Muscle Nerve. 2010. PMID: 19816912

8

Two-year treatment with cyclosporine microemulsion for responder myasthenia gravis patients.

Nagane Y, Suzuki S, Suzuki N, Utsugisawa K. Nagane Y, et al. Among authors: suzuki n, suzuki s. Eur Neurol. 2010;64(3):186-90. doi: 10.1159/000319172. Epub 2010 Aug 17. Eur Neurol. 2010. PMID: 20720424 Clinical Trial.

9

Clinical and immunological differences between early and late-onset myasthenia gravis in Japan.

Suzuki S, Utsugisawa K, Nagane Y, Satoh T, Kuwana M, Suzuki N. Suzuki S, et al. Among authors: suzuki n. J Neuroimmunol. 2011 Jan;230(1-2):148-52. doi: 10.1016/j.jneuroim.2010.10.023. Epub 2010 Nov 12. J Neuroimmunol. 2011. PMID: 21074862

10

Early aggressive treatment strategy against myasthenia gravis.

Nagane Y, Suzuki S, Suzuki N, Utsugisawa K. Nagane Y, et al. Among authors: suzuki n, suzuki s. Eur Neurol. 2011;65(1):16-22. doi: 10.1159/000322497. Epub 2010 Nov 30. Eur Neurol. 2011. PMID: 21116111

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,310 results

Search Page

Filters